Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine
September 10, 2020Research and Development COVID, Macaques, Monkey, Vaccine
Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …
President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes
September 10, 2020Medical Communications All the President's men, Bob Woodward, Trump, Watergate
President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …
Pharmafile.com’s weekly COVID-19 news round-up
September 10, 2020Business Services
The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the …
Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO
September 9, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments
Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
Ali Fattaey appointed Chief Executive Officer of MetaboMed
September 9, 2020Research and Development
MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …
Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds
September 9, 2020Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland
The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …
AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness
September 9, 2020Research and Development AstraZeneca, COVID-19, pharma
Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …
Gatherings of over six people to be banned in England from Monday
September 9, 2020Research and Development Lockdown, coronavirus
England is set to increase lockdown restrictions across the country after a surge in coronavirus cases. Currently, most outdoor gatherings …
Roche to start new trials of Ocrevus to defend multiple sclerosis franchise
September 9, 2020Research and Development MS, MS drug, Roche
Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …
Major vaccine manufacturers sign COVID-19 safety pledge
September 9, 2020Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine
Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19. The companies involved …
FibroGen names appointment for newly created Chief Scientific Officer role
September 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen
FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
Advaxis Chief Financial Officer resigns
September 8, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis
Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
September 8, 2020Manufacturing and Production, Sales and Marketing Cheplapharm, Takeda, pharma
Takeda has revealed it has agreed to divest its non-core portfolio of prescription therapies to Cheplapharm in exchange for an …
Extension study reveals Dupixent’s benefit can last up to three years in moderate-to-severe asthma
September 8, 2020Manufacturing and Production, Research and Development Dupixent, Sanofi, asthma, pharma
New findings have been revealed from an extension study of Sanofi’s interleukin-4 (IL-4) and interleukin-13 (IL-13) inhibitor Dupixent (dupilumab) in …
Mylan reaches agreement with Aspen for their European thrombosis business
September 8, 2020Manufacturing and Production Mylan, aspen
Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million. …
Chinese drug firm says thousands have been vaccinated for COVID-19 on an emergency use scheme
September 8, 2020Manufacturing and Production China Vaccine, China Vaccine approval, coronavirus vaccine
Hundreds of thousands of people in China have been inoculated with two experimental vaccines on an emergency use scheme, according …
Up to 60,000 in the UK may have suffered from “long COVID” new data suggests
September 8, 2020Manufacturing and Production Vaccine, pandemic, vaccines
60,000 people across Britain may have been suffering from prolonged symptoms of coronavirus months after contracting the virus. This is …
Genetech scores sixth FDA approval in lung cancer with Gavreto
September 7, 2020Sales and Marketing Cancer, FDA, Genentech, lung cancer
Genentech’s once-daily oral therapy Gavreto (pralsetinib) has secured FDA backing in the treatment of metastatic rearranged during transfection (RET) fusion-positive …
President of Sanofi France expects COVID-19 vaccine to be priced below ten Euros
September 7, 2020Sales and Marketing COVID-19, GSK, Sanofi
The President of Sanofi France expects the coronavirus vaccine it is developing with GlaxoSmithKline to be priced under 10 Euros. …
Janssen’s Imbruvica secures label expansion in Europe in chronic lymphocytic leukaemia
September 7, 2020Sales and Marketing Europe, Janssen, imbruvica, pharma
The European Commission (EC) has moved to expand the existing approval of Janssen’s Imbruvica (ibrutinib) in chronic lymphocytic leukaemia (CLL) …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
